ATE156518T1 - Gap-gen-sequenzen und diagnoseverwendungen davon - Google Patents

Gap-gen-sequenzen und diagnoseverwendungen davon

Info

Publication number
ATE156518T1
ATE156518T1 AT89908913T AT89908913T ATE156518T1 AT E156518 T1 ATE156518 T1 AT E156518T1 AT 89908913 T AT89908913 T AT 89908913T AT 89908913 T AT89908913 T AT 89908913T AT E156518 T1 ATE156518 T1 AT E156518T1
Authority
AT
Austria
Prior art keywords
gap
daltons
molecular weight
gtp
reduced molecular
Prior art date
Application number
AT89908913T
Other languages
English (en)
Inventor
Gail L Wong
Francis P Mccormick
George Martin
Bonnee Rubinfeld
Edward C O'rourke
Robin Clark
Kirston E Koths
Robert F Halenbeck
Mary M Trahey
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/216,888 external-priority patent/US5104975A/en
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE156518T1 publication Critical patent/ATE156518T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
    • G01N2333/4707—Guanosine triphosphatase activating protein, GAP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89908913T 1988-07-08 1989-06-23 Gap-gen-sequenzen und diagnoseverwendungen davon ATE156518T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/216,888 US5104975A (en) 1988-07-08 1988-07-08 Compositions for detecting ras gene proteins and cancer therapeutics
US23076188A 1988-08-10 1988-08-10
US26080788A 1988-10-21 1988-10-21

Publications (1)

Publication Number Publication Date
ATE156518T1 true ATE156518T1 (de) 1997-08-15

Family

ID=27396345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89908913T ATE156518T1 (de) 1988-07-08 1989-06-23 Gap-gen-sequenzen und diagnoseverwendungen davon

Country Status (7)

Country Link
EP (2) EP0649908A1 (de)
AT (1) ATE156518T1 (de)
AU (1) AU627764B2 (de)
CA (1) CA1339357C (de)
DE (1) DE68928242T2 (de)
IL (1) IL90780A0 (de)
WO (1) WO1990000607A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830684A (en) * 1988-08-10 1998-11-03 Chiron Corporation Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
US5763573A (en) * 1988-08-10 1998-06-09 Chiron Corporation GTPase activating protein fragments
WO1991002749A1 (en) * 1989-08-21 1991-03-07 Cetus Corporation PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
WO1991015582A2 (en) * 1990-03-30 1991-10-17 Cetus Corporation PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
US6238881B1 (en) 1996-11-06 2001-05-29 Onyx Pharmaceuticals, Inc. Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
AU1744900A (en) * 1998-11-23 2000-06-13 Incyte Pharmaceuticals, Inc. Gtpase associated proteins
WO2004047514A2 (en) 2002-11-25 2004-06-10 Sequenom, Inc. Methods for identifying risk of breast cancer and treatments thereof
WO2007001981A2 (en) 2005-06-20 2007-01-04 Ablation Frontiers Ablation catheter
US20220348900A1 (en) * 2019-08-14 2022-11-03 Modernatx, Inc. Processes for purifying downstream products of in vitro transcription

Also Published As

Publication number Publication date
DE68928242D1 (de) 1997-09-11
EP0466688A1 (de) 1992-01-22
AU4034989A (en) 1990-02-05
IL90780A0 (en) 1990-01-18
EP0466688B1 (de) 1997-08-06
AU627764B2 (en) 1992-09-03
EP0649908A1 (de) 1995-04-26
WO1990000607A2 (en) 1990-01-25
CA1339357C (en) 1997-08-26
DE68928242T2 (de) 1997-12-18
WO1990000607A3 (en) 1990-11-01

Similar Documents

Publication Publication Date Title
Ginsburg et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization
Handin et al. Purification and binding properties of human platelet factor four.
Tebo et al. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937.
Nossel et al. Radioimmunoassay of human fibrinopeptide A
Gigli et al. The stoichiometric measurement of the serum inhibitor of the first component of complement by the inhibition of immune hemolysis
Roberts et al. The voltage-sensitive sodium channel from rabbit skeletal muscle. Chemical characterization of subunits.
Leonard et al. The human receptor for T-cell growth factor. Evidence for variable post-translational processing, phosphorylation, sulfation, and the ability of precursor forms of the receptor to bind T-cell growth factor.
Nurden et al. Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia
Marguerie et al. The binding of fibrinogen to its platelet receptor.
US6287756B1 (en) Methods for determining presence of cancer in a sample by determining expression of an SSX gene
ATE156518T1 (de) Gap-gen-sequenzen und diagnoseverwendungen davon
Knutson Insulin-binding peptide. Design and characterization.
Minta et al. Studies on the sub-unit structure of human properdin
RU2002113381A (ru) MASP-3, комплемент-связывающий фермент и его применение
US6548064B1 (en) Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules
Tucker et al. A monoclonal antibody which inhibits the factor Va: factor Xa interaction.
JP2004511253A5 (de)
Traut et al. Ribosomal protein L7/L12 cross-links to proteins in separate regions of the 50 S ribosomal subunit of Escherichia coli.
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
Jouvin et al. Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.
US7385044B2 (en) Isolated peptides which bind to MHC Class II molecules, and uses thereof
ATE433463T1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
Titus et al. Fc (IgG) receptor distributions in homogeneous and heterogeneous cell populations by flow microfluorometry.
DK0462115T3 (da) Diagnostisk proteinmarkør for blærecancer
Celada et al. The expression of I‐A correlates with the uptake of interferon‐γ by macrophages

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee